耐糖能検査市場規模、シェア、成長分析、製品タイプ別、適応疾患別、エンドユーザー別、地域別 - 産業予測、2025-2032年

耐糖能検査の世界市場規模は、2023年に272億米ドルと評価され、2024年の288億米ドルから2032年には455億7,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.9％で成長する見通しです。

糖尿病ケア市場は、糖尿病有病率の増加、技術の進歩、ポイントオブケア（POC）血糖値検査の利点に対する意識の高まりによって、著しい成長を遂げています。針を使わない血糖モニタリング機器の導入は糖尿病管理に革命をもたらし、患者に苦痛のない選択肢を提供しています。Clinical &Laboratories Standard Instituteによる最近の精度ガイドラインの標準化は、特にクリティカルケア環境におけるPOC検査の信頼性を強化しています。2021年の推定糖尿病患者数は5億3,700万人で、2045年には7億8,300万人に達すると予測されています。グルコース診断と短時間検査（STAT）ソリューションに対する需要の高まりは、グルコースレベル管理における患者ケア、効率性、コンプライアンスの改善に重点を置くヘルスケアセクターの姿勢を反映しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

耐糖能検査市場規模：製品タイプ別

• 市場概要
• スマートセンサー
• 血糖値検査キット
• メートル
• 試験紙
• その他

耐糖能検査市場規模：疾患適応症別

• 市場概要
• 反応性低血糖
• 糖尿病低血糖
• 妊娠糖尿病
• インスリン抵抗性
• その他

耐糖能検査市場規模：エンドユーザー別

• 市場概要
• 病院
• クリニック
• 診断センター
• その他

耐糖能検査市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Thermo Fisher Scientific Inc.（United States）
• Medtronic（United States）
• NIPRO（Japan）
• Trividia Health, Inc.（United States）
• Dexcom, Inc.（United States）
• Healius Limited（Australia）
• Penlan Healthcare Ltd.（United Kingdom）
• Quest Diagnostics Incorporated（United States）
• Johnson & Johnson Services, Inc.（United States）
• Abbott（United States）
• Laboratory Corporation of America Holdings（United States）
• ARUP Laboratories（United States）
• Cleveland HeartLab, Inc.（United States）
• Merck KGaA（Germany）
• Bayer AG（Germany）
• Ascensia Diabetes Care Holdings AG（Switzerland）
• E-Zlab Health Services（Canada）
• F. Hoffman-La Roche Ltd（Switzerland）
• LifeScan IP Holdings, LLC（United States）
• Sanofi（France）

結論と推奨事項

Global Glucose Tolerance Test Market size was valued at USD 27.2 billion in 2023 and is poised to grow from USD 28.8 billion in 2024 to USD 45.57 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2025-2032).

The market for diabetes care is experiencing significant growth, driven by increasing diabetes prevalence, technological advancements, and heightened awareness of point-of-care (POC) glucose testing benefits. The introduction of needle-free blood glucose monitoring devices is revolutionizing diabetes management, offering patients a painless alternative. Recent standardization of accuracy guidelines by the Clinical & Laboratories Standard Institute bolsters the reliability of POC testing, especially in critical care environments. With an estimated 537 million people living with diabetes in 2021, forecast projections suggest this number could reach 783 million by 2045. The rising demand for glucose diagnostics and Short Turn-Around Testing (STAT) solutions reflects the healthcare sector's focus on improved patient care, efficiency, and compliance in managing glucose levels.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Glucose Tolerance Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Glucose Tolerance Test Market Segmental Analysis

Global Glucose Tolerance Test Market is segmented by Product Type, Disease Indication, End user and region. Based on Product Type, the market is segmented into Smart Sensors, Blood Glucose Testing Kit, Meters, Test Slips and Others. Based on Disease Indication, the market is segmented into Reactive Hypoglycemia, Diabetes Hypoglycemia, Gestational Diabetes, Insulin Resistance and Others. Based on End user, the market is segmented into Hospitals, Clinics, Diagnostic Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Glucose Tolerance Test Market

The global glucose tolerance test market is significantly driven by the escalating prevalence of diabetes across the globe. Factors contributing to this alarming rise include lifestyle alterations, such as decreased physical activity and unhealthy dietary choices, which in turn amplify the demand for reliable diagnostic tools like glucose tolerance tests. As the awareness surrounding diabetes continues to grow, so does the popularity of these tests, owing to their essential role in the early detection and management of the condition. Consequently, the increasing diabetes rates are compelling healthcare providers and patients alike to prioritize the utilization of glucose tolerance testing, propelling the market forward.

Restraints in the Global Glucose Tolerance Test Market

The global glucose tolerance test market faces significant constraints primarily due to the high costs associated with testing. Many individuals, particularly in economically disadvantaged regions, find these expenses prohibitive, which can lead to a reluctance to undergo essential diagnostic procedures. The financial burden stems from the prices of glucose testing kits, meters, and necessary accessories, along with the frequency of testing required to monitor glucose levels effectively. This situation may hinder market growth by discouraging patients from seeking vital testing services, ultimately affecting overall public health and the early detection of diabetes and related conditions.

Market Trends of the Global Glucose Tolerance Test Market

The Global Glucose Tolerance Test (GTT) market is experiencing significant growth due to advancing diagnostic technologies and increasing diabetes prevalence. As global populations age and unhealthy lifestyle choices rise, there is a marked increase in cases of diabetes and prediabetes, driving the demand for accurate diagnostic tools. Healthcare policies are also evolving to prioritize early intervention, highlighting the necessity for effective screening methods like the GTT. This burgeoning market is fueled by continual innovations in testing methodologies and an urgent need for reliable diagnostics, positioning GTT as a critical component in diabetes management strategies worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Glucose Tolerance Test Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Smart Sensors
• Blood Glucose Testing Kit
• Meters
• Test Slips
• Others

Global Glucose Tolerance Test Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Reactive Hypoglycemia
• Diabetes Hypoglycemia
• Gestational Diabetes
• Insulin Resistance
• Others

Global Glucose Tolerance Test Market Size by End user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Diagnostic Centers
• Others

Global Glucose Tolerance Test Market Size & CAGR (2025-2032)

• North America (Product Type, Disease Indication, End user)
  • US
  • Canada
• Europe (Product Type, Disease Indication, End user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Disease Indication, End user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Disease Indication, End user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Disease Indication, End user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NIPRO (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trividia Health, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Healius Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penlan Healthcare Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARUP Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleveland HeartLab, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• E-Zlab Health Services (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffman-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan IP Holdings, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations